Executives Signal Divergence in Fresh Filings

Insider filings this week revealed a sharp split between buyers and sellers across US stocks.

The boldest move came from SMMT. Summit Therapeutics Chairman and CEO Robert Duggan filed on June 12 disclosing he bought $50M worth of shares at $13.12 each. That's 3.81 million shares added to his position — a major show of confidence from a top executive.

At FISV, five Fiserv insiders filed purchases in the last two days. The CFO, Chief Administration Officer, and three directors all bought shares near $49–51. The coordinated cluster buy is a notable signal. It suggests insiders see the recent dip as a buying opportunity.

On the selling side, DVA CEO Javier Rodriguez filed $14.5M in sales across two days. He unloaded shares at roughly $209 each on June 15 and 16. The Chief Legal Officer filed an additional $1.9M sale on the same dates.

QBTS CFO John Markovich has been steadily offloading D-Wave Quantum stock. He filed over $7.5M in sales in the past two weeks, selling tranches at prices ranging from $24 to $26.

The Walton Family Holdings Trust also filed the sale of $533M in WMT stock this week — routine for the family, but large in dollar terms.

This article is for informational purposes only and does not constitute financial advice.